 |
Strategy& InsiderExploring future trends and their impacts Author: Thomas Solbach, Ghioia Irritier, Jan-Philipp Loch
The Strategy& Insider podcast aims to explore some of the most critical future trends and their impacts. Strategy& talks to industry experts and leading practitioners from different sectors. The conversations will make you more familiar with key developments by providing you with insights that really matter. The first season will tackle some of the most fundamental questions in the healthcare industry. While technology has quickly transformed how we shop, bank, and travel, it yet has to impact on how we receive healthcare. The adoption of digitally enabled tools for diagnostics, treatment, and management, for example, has been rather modest - especially compared to what is already possible. Together with experts across all sectors including pharma executives, leading academics and practitioners at hospitals we will discuss how the healthcare industry is expected to change. Language: en Genres: Business, Health & Fitness, Management, Medicine Contact email: Get it Feed URL: Get it iTunes ID: Get it Trailer: |
Listen Now...
Strategy& Insider Episode 44 - Expanding access to essential medicines
Episode 44
Wednesday, 18 March, 2026
What does it take to get a life-changing medicine from regulatory approval to the patient who needs it? Isabell Remus, Global Head of Biosimilars at Sandoz, reveals why being approved and affordable isn't enough – and how the biosimilar industry learned that trust and education must come before market access. With $320 billion in biologic medicines losing patent exclusivity over the next decade, she explores the strategic complexities of launching at the exact moment a patent expires, the role of diversified manufacturing in strengthening supply chain resilience, and why expanding access to essential medications requires both purpose and commercial viability. An eye-opening conversation on making affordable healthcare a reality for millions of patients worldwide.
